Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

A comprehensive analysis on preservation patterns of gene co-expression networks during Alzheimer's disease progression.

Ray S, Hossain SMM, Khatun L, Mukhopadhyay A.

BMC Bioinformatics. 2017 Dec 20;18(1):579. doi: 10.1186/s12859-017-1946-8.

2.

Diesel engine exhaust accelerates plaque formation in a mouse model of Alzheimer's disease.

Hullmann M, Albrecht C, van Berlo D, Gerlofs-Nijland ME, Wahle T, Boots AW, Krutmann J, Cassee FR, Bayer TA, Schins RPF.

Part Fibre Toxicol. 2017 Aug 30;14(1):35. doi: 10.1186/s12989-017-0213-5.

3.

Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.

Govindpani K, Calvo-Flores Guzmán B, Vinnakota C, Waldvogel HJ, Faull RL, Kwakowsky A.

Int J Mol Sci. 2017 Aug 21;18(8). pii: E1813. doi: 10.3390/ijms18081813. Review.

4.

Visualization of neuritic plaques in Alzheimer's disease by polarization-sensitive optical coherence microscopy.

Baumann B, Woehrer A, Ricken G, Augustin M, Mitter C, Pircher M, Kovacs GG, Hitzenberger CK.

Sci Rep. 2017 Mar 6;7:43477. doi: 10.1038/srep43477.

5.

Classification of Healthy Subjects and Alzheimer's Disease Patients with Dementia from Cortical Sources of Resting State EEG Rhythms: A Study Using Artificial Neural Networks.

Triggiani AI, Bevilacqua V, Brunetti A, Lizio R, Tattoli G, Cassano F, Soricelli A, Ferri R, Nobili F, Gesualdo L, Barulli MR, Tortelli R, Cardinali V, Giannini A, Spagnolo P, Armenise S, Stocchi F, Buenza G, Scianatico G, Logroscino G, Lacidogna G, Orzi F, Buttinelli C, Giubilei F, Del Percio C, Frisoni GB, Babiloni C.

Front Neurosci. 2017 Jan 26;10:604. doi: 10.3389/fnins.2016.00604. eCollection 2016.

6.
7.

The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.

Grizzanti J, Lee HG, Camins A, Pallas M, Casadesus G.

Nutr Res. 2016 Dec;36(12):1305-1315. doi: 10.1016/j.nutres.2016.11.002. Epub 2016 Nov 8. Review.

8.

Effects of multiple training modalities in patients with Alzheimer's disease: a pilot study.

Tai SY, Hsu CL, Huang SW, Ma TC, Hsieh WC, Yang YH.

Neuropsychiatr Dis Treat. 2016 Nov 1;12:2843-2849. eCollection 2016.

9.

Alzheimer's disease: presence and role of microRNAs.

Basavaraju M, de Lencastre A.

Biomol Concepts. 2016 Aug 1;7(4):241-52. doi: 10.1515/bmc-2016-0014. Review.

10.

Classification of Single Normal and Alzheimer's Disease Individuals from Cortical Sources of Resting State EEG Rhythms.

Babiloni C, Triggiani AI, Lizio R, Cordone S, Tattoli G, Bevilacqua V, Soricelli A, Ferri R, Nobili F, Gesualdo L, Millán-Calenti JC, Buján A, Tortelli R, Cardinali V, Barulli MR, Giannini A, Spagnolo P, Armenise S, Buenza G, Scianatico G, Logroscino G, Frisoni GB, Del Percio C.

Front Neurosci. 2016 Feb 23;10:47. doi: 10.3389/fnins.2016.00047. eCollection 2016.

11.
12.

Discovering Alzheimer Genetic Biomarkers Using Bayesian Networks.

Sherif FF, Zayed N, Fakhr M.

Adv Bioinformatics. 2015;2015:639367. doi: 10.1155/2015/639367. Epub 2015 Aug 23.

13.

Amyloid-β Peptide Exacerbates the Memory Deficit Caused by Amyloid Precursor Protein Loss-of-Function in Drosophila.

Bourdet I, Lampin-Saint-Amaux A, Preat T, Goguel V.

PLoS One. 2015 Aug 14;10(8):e0135741. doi: 10.1371/journal.pone.0135741. eCollection 2015.

14.

Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment.

Chakrabarti S, Khemka VK, Banerjee A, Chatterjee G, Ganguly A, Biswas A.

Aging Dis. 2015 Aug 1;6(4):282-99. doi: 10.14336/AD.2014.002. eCollection 2015 Aug. Review.

15.

Non-monotonic reorganization of brain networks with Alzheimer's disease progression.

Kim H, Yoo K, Na DL, Seo SW, Jeong J, Jeong Y.

Front Aging Neurosci. 2015 Jun 9;7:111. doi: 10.3389/fnagi.2015.00111. eCollection 2015.

16.

Is the Alzheimer's disease cortical thickness signature a biological marker for memory?

Busovaca E, Zimmerman ME, Meier IB, Griffith EY, Grieve SM, Korgaonkar MS, Williams LM, Brickman AM.

Brain Imaging Behav. 2016 Jun;10(2):517-23. doi: 10.1007/s11682-015-9413-5.

17.

Curcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer's Disease.

Patil R, Gangalum PR, Wagner S, Portilla-Arias J, Ding H, Rekechenetskiy A, Konda B, Inoue S, Black KL, Ljubimova JY, Holler E.

Macromol Biosci. 2015 Sep;15(9):1212-7. doi: 10.1002/mabi.201500062. Epub 2015 Jun 2.

18.

Methyllycaconitine alleviates amyloid-β peptides-induced cytotoxicity in SH-SY5Y cells.

Zheng X, Xie Z, Zhu Z, Liu Z, Wang Y, Wei L, Yang H, Yang H, Liu Y, Bi J.

PLoS One. 2014 Oct 31;9(10):e111536. doi: 10.1371/journal.pone.0111536. eCollection 2014.

19.

Memory banking: a life story intervention for aging preparation and mental health promotion.

Zanjani F, Downer BG, Hosier AF, Watkins JD.

J Aging Health. 2015 Mar;27(2):355-76. doi: 10.1177/0898264314551170. Epub 2014 Sep 19.

20.

Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials.

Jia Q, Deng Y, Qing H.

Biomed Res Int. 2014;2014:837157. doi: 10.1155/2014/837157. Epub 2014 Jul 17. Review.

Supplemental Content

Support Center